Sesamolin affects both natural killer cells and cancer cells in order to create an optimal environment for cancer...

Area of Science:

• Immunology
• Pharmacology
• Cancer Biology

Background:

• Previous research indicated sesamolin enhances cancer cell susceptibility to natural killer (NK) cell-mediated killing.
• The direct impact of sesamolin on NK cell function remained to be elucidated.

Purpose of the Study:

• To investigate the direct effects of sesamolin on the cytotoxic activity and function of NK cells.
• To identify the molecular mechanisms underlying sesamolin's influence on NK cells.

Main Methods:

• NK-92MI and Raji cells were treated with varying concentrations of sesamolin.
• Cytolytic activity assays were performed to measure NK cell-mediated killing.
• Expression of degranulation marker CD107a and production of Interferon-gamma (IFN-γ) were analyzed.
• Phosphorylation of p38, ERK1/2, and JNK pathways was assessed.

Main Results:

• Sesamolin treatment dose-dependently increased NK-92MI cell cytolytic activity.
• Optimal cytolytic activity was observed at specific sesamolin concentrations for both cell types.
• Sesamolin enhanced CD107a expression and IFN-γ production in NK cells.
• Sesamolin's effects were mediated by the phosphorylation of p38, ERK1/2, and JNK signaling pathways.

Conclusions:

• Sesamolin directly stimulates NK cells, enhancing their cytotoxic potential against cancer cells.
• The findings support sesamolin as a potential immunomodulatory agent for cancer therapy.
• Sesamolin's mechanism involves activation of key intracellular signaling pathways in NK cells.